Lilly CEO Sees Supply Squeeze for New Antibody Drug as Covid-19 Cases Surge

(Bloomberg) -- In a mere nine months, Eli Lilly & Co. accomplished an unprecedented feat: The drug giant took a blood sample from one of the first U.S. patients to recover from Covid-19, identified...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.